CN1656083A - 具有抗菌活性的新的杂环化合物、它们的制备方法和含有它们的药物组合物 - Google Patents

具有抗菌活性的新的杂环化合物、它们的制备方法和含有它们的药物组合物 Download PDF

Info

Publication number
CN1656083A
CN1656083A CNA018224210A CN01822421A CN1656083A CN 1656083 A CN1656083 A CN 1656083A CN A018224210 A CNA018224210 A CN A018224210A CN 01822421 A CN01822421 A CN 01822421A CN 1656083 A CN1656083 A CN 1656083A
Authority
CN
China
Prior art keywords
alkyl
oxazolidine
oxo
salt
phenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA018224210A
Other languages
English (en)
Chinese (zh)
Inventor
S·纳特桑
J·达斯
J·伊克巴勒
S·K·马加迪
N·V·S·R·马米迪
R·拉马努詹
B·孙达拉巴布
B·B·洛雷
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dr Reddys Research Foundation
Original Assignee
Dr Reddys Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dr Reddys Research Foundation filed Critical Dr Reddys Research Foundation
Publication of CN1656083A publication Critical patent/CN1656083A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18—Oxygen atoms
    • C07D263/20—Oxygen atoms attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18—Oxygen atoms
    • C07D263/20—Oxygen atoms attached in position 2
    • C07D263/22—Oxygen atoms attached in position 2 with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to other ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18—Oxygen atoms
    • C07D263/20—Oxygen atoms attached in position 2
    • C07D263/24—Oxygen atoms attached in position 2 with hydrocarbon radicals, substituted by oxygen atoms, attached to other ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
CNA018224210A 2000-12-26 2001-12-26 具有抗菌活性的新的杂环化合物、它们的制备方法和含有它们的药物组合物 Pending CN1656083A (zh)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
IN1124/MAS/2000 2000-12-26
IN1124MA2000 2000-12-26
IN15MA2001 2001-01-15
IN15/MAS/200 2001-01-15
PCT/IN2001/000227 WO2002051819A2 (en) 2000-12-26 2001-12-26 Heterocyclic compounds having antibacterial activity, process for their preparation and pharmaceutical compositions containing them

Publications (1)

Publication Number Publication Date
CN1656083A true CN1656083A (zh) 2005-08-17

Family

ID=26324889

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA018224210A Pending CN1656083A (zh) 2000-12-26 2001-12-26 具有抗菌活性的新的杂环化合物、它们的制备方法和含有它们的药物组合物

Country Status (21)

Country Link
US (2) US7030148B2 (https=)
EP (1) EP1345913A2 (https=)
JP (1) JP2004525876A (https=)
KR (1) KR20030063472A (https=)
CN (1) CN1656083A (https=)
BG (1) BG108022A (https=)
BR (1) BR0116571A (https=)
CA (1) CA2433138A1 (https=)
CZ (1) CZ20031799A3 (https=)
EE (1) EE200300254A (https=)
HR (1) HRP20030522A2 (https=)
HU (1) HUP0302580A2 (https=)
IL (1) IL156662A0 (https=)
MX (1) MXPA03005822A (https=)
NO (1) NO20032926L (https=)
NZ (1) NZ526716A (https=)
PL (1) PL363616A1 (https=)
RU (1) RU2322444C2 (https=)
SK (1) SK8202003A3 (https=)
WO (1) WO2002051819A2 (https=)
YU (1) YU52403A (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101720325B (zh) * 2007-08-06 2013-04-24 上海盟科药业有限公司 用于治疗细菌感染的抗菌邻-氟苯基噁唑烷酮

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9928568D0 (en) 1999-12-03 2000-02-02 Zeneca Ltd Chemical compounds
GB0009803D0 (en) 2000-04-25 2000-06-07 Astrazeneca Ab Chemical compounds
US7396847B2 (en) 2001-09-11 2008-07-08 Astrazeneca Ab Oxazolidinone and/or isoxazoline as antibacterial agents
US20060293315A1 (en) * 2001-12-21 2006-12-28 Dr. Reddy's Laboratories Ltd. Intermediates of novel heterocyclic compounds having antibacterial activity and process for their preparation
US6914058B2 (en) * 2002-01-18 2005-07-05 Dr. Reddy's Laboratories, Limited Antibacterial compounds: process for their preparation and pharmaceutical compositions containing them
DE10233817A1 (de) * 2002-07-25 2004-02-12 Aventis Pharma Deutschland Gmbh Substituierte Diarylheterocyclen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
US7141561B2 (en) 2002-07-25 2006-11-28 Sanofi-Aventis Deutschland Gmbh Substituted diaryl heterocycles, process for their preparation and their use as medicaments
US20080214565A1 (en) * 2003-04-07 2008-09-04 Anita Mehta Oxazolidinone Derivatives as Antimicrobials
DE602004027811D1 (de) 2003-07-02 2010-08-05 Kyorin Seiyaku Kk Cyclopropylgruppensubstituierte oxazolidinonantibiotika und derivate davon
EP1654259A1 (en) * 2003-07-02 2006-05-10 Merck & Co., Inc. Cyclopropyl group substituted oxazolidinone antibiotics and derivatives thereof
WO2005035528A2 (en) * 2003-10-14 2005-04-21 Dr. Reddy's Laboratories Ltd. Triazole derivatives as antibacterial agents
KR100854211B1 (ko) 2003-12-18 2008-08-26 동아제약주식회사 신규한 옥사졸리디논 유도체, 그의 제조방법 및 이를유효성분으로 하는 항생제용 약학 조성물
EP1866295A2 (en) * 2005-02-24 2007-12-19 Teva Pharmaceutical Industries Ltd Processes for the preparation of linezolid intermediate
ES2524922T3 (es) 2005-05-10 2014-12-15 Intermune, Inc. Derivados de piridona para modular el sistema de proteína cinasa activada por estrés
CA2726588C (en) 2008-06-03 2019-04-16 Karl Kossen Compounds and methods for treating inflammatory and fibrotic disorders
US9540322B2 (en) 2008-08-18 2017-01-10 Yale University MIF modulators
PE20110368A1 (es) * 2008-08-18 2011-06-13 Univ Yale Moduladores de mif
US9643922B2 (en) 2008-08-18 2017-05-09 Yale University MIF modulators
KR101918678B1 (ko) 2009-02-03 2018-11-14 머크 샤프 앤드 돔 코포레이션 Ｒ)-3-(4-(2-(2-메틸테트라졸-5-일)피리딘-5-일)-3-플루오로페닐)-5-히드록시메틸 옥사졸리딘-2-온 디히드로겐 포스페이트의 결정형
CN101798302B (zh) * 2009-02-06 2014-11-05 上海盟科药业有限公司 抗生素类药物1-(邻-氟苯基)二氢吡啶酮的合成及生产的方法和工艺
WO2014045292A1 (en) * 2012-09-20 2014-03-27 Symed Labs Limited Improved process for the preparation of linezolid intermediate
AR092742A1 (es) 2012-10-02 2015-04-29 Intermune Inc Piridinonas antifibroticas
CN105612166B (zh) 2014-02-21 2019-02-19 上海盟科药业有限公司 治疗用水溶性(o-羰基)氨基磷酸酯前药
MX382781B (es) 2014-04-02 2025-03-13 Intermune Inc Piridinonas anti-fibroticas.
WO2017066964A1 (en) * 2015-10-22 2017-04-27 Merck Sharp & Dohme Corp. Oxazolidinone compounds and methods of use thereof as antibacterial agents
GB2550437B (en) * 2016-05-20 2021-06-23 Bugworks Res Inc Heterocyclic compounds useful as anti-bacterial agents and method for production
US12109203B2 (en) 2018-07-25 2024-10-08 Zydus Lifesciences Limited Substituted oxazolidinones for the treatment of mammalian infections
WO2020234636A1 (en) 2019-05-17 2020-11-26 Cadila Healthcare Limited Novel compounds for the treatment of mammalian infections
CN110301433A (zh) * 2019-07-25 2019-10-08 河南精怡达生物科技有限公司 一种含有微量元素组合的猪精液体外常温保存剂

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2987505A (en) * 1958-03-04 1961-06-06 Gen Aniline & Film Corp Compositions of polymeric nu-vinyl-2-oxazolidone and halogens
US3651079A (en) 1968-11-25 1972-03-21 Colgate Palmolive Co 1-aryl-5-hydroxyalkyl-hydantoins
GB1408010A (en) 1972-11-20 1975-10-01 Geistlich Soehne Ag Sulphamoylphenyl-imidazolidinones
US4174958A (en) 1978-01-09 1979-11-20 Shell Oil Company Anilide derivative herbicides
FR2571364B1 (fr) * 1984-10-09 1987-07-17 Oreal Nouveau procede de preparation de nitroparaphenylenediamines n,n'-disubstituees, nouvelles oxazolidones utilisees dans ce procede, nouvelles nitroparaphenylenediamines n,n'-disubstituees obtenues selon ce procede et compositions tinctoriales contenant les nitroparaphenylenediamines n,n'-disubstituees obtenues selon ledit procede
SK283420B6 (sk) * 1992-05-08 2003-07-01 Pharmacia & Upjohn Company Antimikrobiálne oxazolidinóny obsahujúce substituované diazínové skupiny
MY115155A (en) 1993-09-09 2003-04-30 Upjohn Co Substituted oxazine and thiazine oxazolidinone antimicrobials.
JP3933198B2 (ja) 1994-10-26 2007-06-20 ファルマシア・アンド・アップジョン・カンパニー フェニルオキサゾリジノン抗菌剤
US6124334A (en) 1995-02-03 2000-09-26 Pharmacia & Upjohn Company Hetero-aromatic ring substituted phenyloxazolidinone antimicrobials
GB9601666D0 (en) 1996-01-27 1996-03-27 Zeneca Ltd Chemical compounds
US6087496A (en) * 1998-05-22 2000-07-11 G. D. Searle & Co. Substituted pyrazoles suitable as p38 kinase inhibitors
JPH11322729A (ja) * 1998-03-09 1999-11-24 Hokuriku Seiyaku Co Ltd ジチオカルバミド酸誘導体
US6441005B1 (en) 1999-07-28 2002-08-27 Pharmacia & Upjohn Company Oxazolidinone compounds and compositions, and methods of using the same
GB0118407D0 (en) 2001-07-27 2001-09-19 Cipla Ltd Oxazolidinone derivatives as antibacterial agents

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101720325B (zh) * 2007-08-06 2013-04-24 上海盟科药业有限公司 用于治疗细菌感染的抗菌邻-氟苯基噁唑烷酮

Also Published As

Publication number Publication date
CZ20031799A3 (cs) 2004-02-18
BG108022A (bg) 2004-09-30
NO20032926L (no) 2003-08-25
BR0116571A (pt) 2004-03-02
EP1345913A2 (en) 2003-09-24
WO2002051819A9 (en) 2003-08-07
CA2433138A1 (en) 2002-07-04
KR20030063472A (ko) 2003-07-28
EE200300254A (et) 2003-12-15
RU2003123104A (ru) 2005-03-10
SK8202003A3 (en) 2004-07-07
RU2322444C2 (ru) 2008-04-20
US20040059120A1 (en) 2004-03-25
PL363616A1 (en) 2004-11-29
NO20032926D0 (no) 2003-06-25
JP2004525876A (ja) 2004-08-26
HRP20030522A2 (en) 2005-06-30
US7183301B2 (en) 2007-02-27
US20030065175A1 (en) 2003-04-03
IL156662A0 (en) 2004-01-04
US7030148B2 (en) 2006-04-18
MXPA03005822A (es) 2004-05-04
YU52403A (sh) 2006-03-03
HUP0302580A2 (hu) 2003-11-28
NZ526716A (en) 2005-08-26
WO2002051819A3 (en) 2002-12-05
WO2002051819A2 (en) 2002-07-04

Similar Documents

Publication Publication Date Title
CN1656083A (zh) 具有抗菌活性的新的杂环化合物、它们的制备方法和含有它们的药物组合物
CN1293076C (zh) 过氧化物酶体增殖剂应答性受体δ的活化剂
CN1280269C (zh) 脂肪族含氮五员环化合物
CN1221548C (zh) 含有砜亚氨基官能团的噁唑烷酮
CN1211384C (zh) 噻二唑基和噁二唑基苯基噁唑烷酮抗菌剂
CN1036006C (zh) 抗菌素化合物碳代青霉烯
CN100347185C (zh) 新的无环核苷膦酸酯衍生物,其盐及其制备方法
CN1138582A (zh) 含杂原子的苯并环戊烷-噁唑烷酮
CN1312800A (zh) 治疗用的联芳基衍生物
CN1028529C (zh) 内亚苯基氧杂双环庚基取代的前列腺素类似物的制法
CN1433413A (zh) 新的噁唑烷酮衍生物及其制备方法
CN1122803A (zh) 苯并噁唑基-和苯并噻唑基噁唑烷酮类化合物
HK1054384B (zh) 4-嘧啶基-n-酰基-l-苯基丙氨酸类化合物
CN1447808A (zh) 作为杀菌剂的噁唑烷酮衍生物
CN1167111A (zh) 噻唑烷二酮衍生物及其制造方法和含该衍生物的药物组合物
CN1242014A (zh) 新型杂环酰胺化合物及其医药用途
CN1432015A (zh) 可用作细胞增殖抑制剂的被1,1－二氧代异噻唑烷取代的吲唑
CN1059908A (zh) 嘧啶衍生物及其药物
CN1046162A (zh) 5-烷基喹诺酮羧酸
CN1159303C (zh) 单环β-内酰胺类抗生素衍生物的中间体的制备方法
CN1520412A (zh) 作为抗菌剂的新噁唑烷酮衍生物
CN1221738A (zh) 喹啉酮衍生物、其制备方法和抗变态反应剂
CN1639133A (zh) 新抗菌化合物、其制备方法和含有它们的药物组合物
CN1291979C (zh) 咪唑化合物及其作为腺苷脱氨酶抑制剂的用途
CN1020104C (zh) 3-丙烯基头孢烯衍生物的制备方法

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication